TTP054

· vTv Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TTP054, covering 2017-02-10 to 2017-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes [Phase 2]